Cargando…
Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption
BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218270/ https://www.ncbi.nlm.nih.gov/pubmed/32403086 http://dx.doi.org/10.1016/j.ebiom.2020.102775 |
_version_ | 1783532765090676736 |
---|---|
author | Ma, Lingman Ye, Xinyue Sun, Pengbo Xu, Pengfei Wang, Liping Liu, Zixiang Huang, Xiaowei Bai, Zhaoshi Zhou, Changlin |
author_facet | Ma, Lingman Ye, Xinyue Sun, Pengbo Xu, Pengfei Wang, Liping Liu, Zixiang Huang, Xiaowei Bai, Zhaoshi Zhou, Changlin |
author_sort | Ma, Lingman |
collection | PubMed |
description | BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino acids (AA) in the longer chain of EeCentrocin 1 (from the edible sea-urchin Echinus esculentus) were truncated and underwent further modification. To produce lead peptides with low toxicity and high efficacy, the antimicrobial activity or cytotoxicity of peptides was evaluated against various multidrug-resistant bacteria/fungi or mammalian cells in vivo/ in vitro. In addition, the stability and modes of action of the lead peptide were investigated. FINDINGS: EC1-17KV displayed potent activity and an expanded antimicrobial spectrum, especially against drug-resistant gram-negative bacteria and fungi, attributable to its enhanced amphiphilicity and net charge. In addition, it exhibits bactericidal/fungicidal activity and effectively increased the animal survival rate and mitigated the histopathological damage induced by multidrug-resistant P. aeruginosa or C. albicans in infected mice or G. mellonella. Moreover, EC1-17KV had a poor ability to induce resistance in bacteria and fungi and exhibited desirable high-salt/high-temperature tolerance properties. In bacteria, EC1-17KV promoted divalent cation release to damage bacterial membrane integrity. In fungi, it changed C. albicans membrane fluidity to increase membrane permeabilization or reduced hyphal formation to suppress biofilm formation. INTERPRETATION: EC1-17KV is a promising lead peptide for the development of antimicrobial agents against antibiotic resistant bacteria and fungi. FUNDING: This work was funded by the National Natural Science Foundation of China (No. 81673483, 81803591); National Science and Technology Major Project Foundation of China (2019ZX09721001-004-005); National Key Research and Development Program of China (2018YFA0902000); "Double First-Class" University project (CPU2018GF/GY16); Natural Science Foundation of Jiangsu Province of China (No. BK20180563); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. |
format | Online Article Text |
id | pubmed-7218270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72182702020-05-15 Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption Ma, Lingman Ye, Xinyue Sun, Pengbo Xu, Pengfei Wang, Liping Liu, Zixiang Huang, Xiaowei Bai, Zhaoshi Zhou, Changlin EBioMedicine Research paper BACKGROUND: The antibiotic resistance and biofilm formation of pathogenic microbes exacerbate the difficulties of anti-infection therapy in the clinic. The structural modification of antimicrobial peptides (AMP) is an effective strategy to develop novel anti-infective agents. METHOD: Seventeen amino acids (AA) in the longer chain of EeCentrocin 1 (from the edible sea-urchin Echinus esculentus) were truncated and underwent further modification. To produce lead peptides with low toxicity and high efficacy, the antimicrobial activity or cytotoxicity of peptides was evaluated against various multidrug-resistant bacteria/fungi or mammalian cells in vivo/ in vitro. In addition, the stability and modes of action of the lead peptide were investigated. FINDINGS: EC1-17KV displayed potent activity and an expanded antimicrobial spectrum, especially against drug-resistant gram-negative bacteria and fungi, attributable to its enhanced amphiphilicity and net charge. In addition, it exhibits bactericidal/fungicidal activity and effectively increased the animal survival rate and mitigated the histopathological damage induced by multidrug-resistant P. aeruginosa or C. albicans in infected mice or G. mellonella. Moreover, EC1-17KV had a poor ability to induce resistance in bacteria and fungi and exhibited desirable high-salt/high-temperature tolerance properties. In bacteria, EC1-17KV promoted divalent cation release to damage bacterial membrane integrity. In fungi, it changed C. albicans membrane fluidity to increase membrane permeabilization or reduced hyphal formation to suppress biofilm formation. INTERPRETATION: EC1-17KV is a promising lead peptide for the development of antimicrobial agents against antibiotic resistant bacteria and fungi. FUNDING: This work was funded by the National Natural Science Foundation of China (No. 81673483, 81803591); National Science and Technology Major Project Foundation of China (2019ZX09721001-004-005); National Key Research and Development Program of China (2018YFA0902000); "Double First-Class" University project (CPU2018GF/GY16); Natural Science Foundation of Jiangsu Province of China (No. BK20180563); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Elsevier 2020-05-11 /pmc/articles/PMC7218270/ /pubmed/32403086 http://dx.doi.org/10.1016/j.ebiom.2020.102775 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research paper Ma, Lingman Ye, Xinyue Sun, Pengbo Xu, Pengfei Wang, Liping Liu, Zixiang Huang, Xiaowei Bai, Zhaoshi Zhou, Changlin Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title | Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title_full | Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title_fullStr | Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title_full_unstemmed | Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title_short | Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption |
title_sort | antimicrobial and antibiofilm activity of the eecentrocin 1 derived peptide ec1-17kv via membrane disruption |
topic | Research paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218270/ https://www.ncbi.nlm.nih.gov/pubmed/32403086 http://dx.doi.org/10.1016/j.ebiom.2020.102775 |
work_keys_str_mv | AT malingman antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT yexinyue antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT sunpengbo antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT xupengfei antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT wangliping antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT liuzixiang antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT huangxiaowei antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT baizhaoshi antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption AT zhouchanglin antimicrobialandantibiofilmactivityoftheeecentrocin1derivedpeptideec117kvviamembranedisruption |